Israeli company Brainsway Ltd., which develops non-invasive treatments using transcranial magnetic stimulation (TMS), will launch its Deep TMS product in the US this month. The device, which is intended for treatment of major depression, won FDA approval earlier this year.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

Israel Invests Millions To Help AI Comprehend Hebrew, Arabic
September 21, 2023

Cybersecurity Startup Cato Raises $238M With $3B Valuation
September 21, 2023

Israel, UK Ink Deal For Greater Innovation Collaboration
September 21, 2023

ALS Drug Receives Patent In Israel, Europe, Japan
September 20, 2023
Facebook comments